PharmEasy still 92% below its peak $5.6 billion valuation, investor estimates

Quick Summary:

Indian online pharmacy startup PharmEasy, once valued at $5.6 billion, is still about 92% below its peak valuation, according to estimates by its investor Janus Henderson.

Spotter, the startup that provides financial solutions to content creators, announced Tuesday the launch of its new AI-powered creative suite.

The once-flying startup had filed for an $843 million IPO in November 2021 but later deferred the plan.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Manish Singh

Category: Technology

Markets: United StatesBrazilChinaIndiaNetherlands

Topics: PharmEasy Janus Henderson Startups

Source Website Secure: Yes (HTTPS)

News Sentiment: Positive

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-09-04 @ 03:38:32 (10 hours ago)

News Timezone: GMT -5:00

News Source URL: techcrunch.com

Language: English

Article Length: 917 words

Reading Time: 6 minutes read

Sentences: 52 lines

Sentence Length: 18 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © TechCrunch

News ID: 22362540

View Article Analysis

About TechCrunch

Main Topics: Technology

Official Website: techcrunch.com

Update Frequency: 13 posts per day

Year Established: 2005

Headquarters: United States

News Last Updated: 13 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT -5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #20

Publisher Details

Frequently Asked Questions